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CoA synthase mediates the last two steps in the se-
quence of enzymatic reactions, leading to CoA biosyn-
thesis. We have recently identified cDNA for CoA syn-
thase and demonstrated that it encodes a bifunctional
enzyme possessing 4-phosphopantetheine adenylyl-
transferase and dephospho-CoA kinase activities. Mo-
lecular cloning of CoA synthase provided us with neces-
sary tools to study subcellular localization and the
regulation of this bifunctional enzyme. Transient ex-
pression studies and confocal microscopy allowed us to
demonstrate that full-length CoA synthase is associated
with the mitochondria, whereas the removal of the N-
terminal region relocates the enzyme to the cytosol. In
addition, we showed that the N-terminal sequence of
CoA synthase (amino acids 1–29) exhibits a hydrophobic
profile and targets green fluorescent protein exclusively
to mitochondria. Further analysis, involving subcellu-
lar fractionation and limited proteolysis, indicated
that CoA synthase is localized on the mitochondrial
outer membrane. Moreover, we demonstrate for the first
time that phosphatidylcholine and phosphatidylethano-
lamine, which are the main components of the mito-
chondrial outer membrane, are potent activators of both
enzymatic activities of CoA synthase in vitro. Taken
together, these data provide the evidence that the final
stages of CoA biosynthesis take place on mitochondria
and the activity of CoA synthase is regulated by
phospholipids.
Coenzyme A (CoA) is an essential cofactor in numerous bio-
synthetic and degradative pathways of cellular metabolism,
including the tricarboxylic acid cycle, the synthesis and -oxi-
dation of fatty acids, and the degradation of amino acids. The
biosynthesis of CoA is highly conserved from prokaryotes to
eukaryotes and involves five enzymatic steps, which use pan-
tothenate (vitamin B5), ATP, and cysteine (1, 2). The pathway
is initiated by pantothenate kinase, which converts pantothenic
acid into 4-phosphopantothenic acid. The 4-phosphopantothe-
noylcysteine synthase and phosphopantothenoylcysteine decar-
boxylase catalyze the formation of 4-phospho-pantothenoylcys-
teine and 4-phosphopantetheine (4PP),1 respectively. The last
two steps of CoA biosynthesis are mediated by CoA synthase,
which is a bifunctional enzyme, possessing 4PP adenylyltrans-
ferase and dephospho-CoA kinase activities. Therefore, CoA
synthase mediates coupling of phosphopantetheine with ATP
to form dephospho-CoA and the subsequent phosphorylation of
the 3-hydroxyl group to generate CoA.
Biosynthesis of CoA is regulated by various extracellular
stimuli, including nutrients, hormones of metabolic homeosta-
sis, and cellular metabolites. Numerous studies have demon-
strated that tissue level of CoA is reduced by insulin, glucose,
fatty acids, and pyruvate, whereas glucagon and glucocorti-
coids stimulate CoA biosynthesis (3–6). Changes in the rate of
CoA biosynthesis occur with fasting, re-feeding, and several
pathological conditions, such as diabetes, Reye syndrome, can-
cer, vitamin B12 deficiency, and cardiac hypertrophy (7–11).
Moreover, the ratio between CoA and its thioester derivatives
is important for maintaining cellular homeostasis. It has been
demonstrated that starvation and diabetes increase the Acyl-
CoA:CoA ratio, which leads to mobilization of fatty acids (2, 12).
In addition, the ratio between acyl-CoA and CoA affects the
activity of a number of cellular enzymes, including pyruvate
dehydrogenase, pyruvate carboxylase, carnitine acetyltrans-
ferase, and citrate synthase (13–15).
The analysis of CoA metabolic intermediates in bacteria and
mammalian cells demonstrated that both pantothenate and
4PP could accumulate in significant amounts, indicating the
existence of two rate-limiting steps in CoA biosynthesis (16,
17). Studies from several laboratories provided evidence that
pantothenate kinase is the main regulatory enzyme in CoA
biosynthesis (3, 17). The activity of pantothenate kinase is
strongly inhibited in a feedback regulatory mode by CoA and
all of its acyl esters (6, 18, 19). So far, very little is known about
the regulation of 4PP adenylyltransferase activity of CoA syn-
thase, which seems to be another control point in maintaining
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CoA homeostasis. No physiological regulators of CoA synthase
have been reported so far. However, the regulation of this step
may control the re-utilization of 4PP arising from the turnover
of the acyl carrier protein or the degradation of CoA by a
phosphodiesterase.
The compartmentalization of the CoA biosynthetic pathway
is very important but is not well understood. In baker’s yeast,
a multienzymatic CoA-synthesizing complex has been isolated
and shown to contain all enzymatic activities involved in CoA
biosynthesis (20, 21). However, such a complex has not been
observed in other organisms. In mammalian cells, the first
three enzymes in the pathway of CoA biosynthesis are cytosolic
proteins (17, 22, 23). The data on the localization of CoA syn-
thase are somewhat controversial. The 4PP adenylyltrans-
ferase and dephospho-CoA kinase activities of CoA synthase
have been reported in the cytosol (3), the mitochondrial outer
membrane (25) and in the mitochondrial matrix (26). Molecular
cloning of CoA synthase cDNA has facilitated the task of ana-
lyzing subcellular localization of the enzyme and its regulation
in response to various extracellular stimuli and metabolic
changes (27–29).
In this study, we demonstrate by confocal microscopy and
subcellular fractionation that CoA synthase is localized on
mitochondria. Furthermore, CoA synthase was mapped more
precisely to the mitochondrial outer membrane. Mitochondrial
localization of CoA synthase was shown to be mediated by the
N-terminal sequence, which targets green fluorescent protein
solely to mitochondria. We also provide evidence for the first
time that both activities of CoA synthase are activated by
phosphatidylcholine and phosphatidylethanolamine. This
study demonstrates that the last two steps of CoA biosynthesis
occur on the outer mitochondrial membrane and that phospho-
lipids can modulate the activity of CoA synthase.
EXPERIMENTAL PROCEDURES
Materials—Tissue culture media and reagents were purchased from
Invitrogen; insulin-like growth factor, epidermal growth factor (EGF),
phorbol 12-myristate 13-acetate, dephospho-CoA, phosphatidylcholine,
phosphatidylserine, phosphatidylethanolamine, and phosphatidylinosi-
tol were from Sigma; mitochondrial marker MitoTracker Orange CMT-
MRos was from Molecular Probes. All chemicals used in this study were
of analytical reagent grade.
Cell Cultures and Antibodies—MCF7 and human embryonic kidney
293 cells were grown in Dulbecco’s modified Eagle’s medium supple-
mented with 10% fetal calf serum. NIH3T3 cells were maintained in
Dulbecco’s modified Eagle’s medium supplemented with 10% donor calf
serum. The anti-VDAC1, anti-Mn-SOD and anti-Myc monoclonal anti-
bodies (9E-10) were purchased from Santa Cruz Biotechnology. Fluo-
rescein isothiocyanate-conjugated goat anti-mouse antibodies were
from Jackson ImmunoResearch Laboratories. Generation of rabbit
polyclonal anti-CoAsy antibodies was described previously (27).
Plasmid Construction, Expression and Purification of Recombinant
Proteins—Full-length coding sequence of CoAsy was PCR-amplified by
Vent polymerase and cloned into pFastBacHTb vector in frame with the
His-tag epitope at the N terminus (Invitrogen). Generation of recombi-
nant baculovirus was carried out using Bac-to-Bac baculovirus expres-
sion system (Invitrogen). Amplification of recombinant baculovirus,
infection of Sf9 cells, and affinity purification of His-CoAsy were per-
formed according to manufacturer’s recommendations. To generate
mammalian expression constructs, PCR-amplified sequences of full-
length CoAsy (amino acids 1–563), TMCoAsy (amino acids 29–563),
NCoAsy (amino acids 187–563), and dPCoAK (amino acids 349–563)
were cloned into pcDNA3.1 vector (Invitrogen) in frame with the C-
terminal Myc-tag epitope. An 87-bp cDNA fragment coding for the first
29 amino acids of CoAsy was amplified by PCR and cloned in frame with
the 5-end of the green fluorescent protein (EGFP) cDNA into
pEGFP-N1 vector (Clontech). All constructs were verified by DNA se-
quencing using an ABI 373A automated sequencer.
Immunofluorescence Analysis—NIH3T3 cells, grown on 13-mm cov-
erslips, were transfected with 0.5 g of pcDNA 3.1-CoAsy, pcDNA
3.1-TMCoAsy, pcDNA 3.1-dPCoAK, or pcDNA 3.1-NCoAsy con-
structs using PolyFect under recommended conditions (QIAGEN).
Transfected cells were cultured for 24 h and then treated with 100 nM
MitoTracker Orange CMTMRos (Molecular Probes) for 15 min before
fixation with 4% paraformaldehyde and permeabilization with 0.2%
Triton X-100. Primary anti-Myc antibodies (1:1000 dilution) were incu-
bated with fixed cells for 1 h followed by incubation with secondary
fluorescein isothiocyanate-anti-mouse antibodies. Transfection of hu-
man embryonic kidney 293 cells with pEGFP-N1 and pEGFP-N1-
CoAsyN plasmids was carried out using LipofectAMINE according to
manufacturer’s recommendations (Invitrogen). Fluorescently labeled
cells were viewed with a Zeiss LSM510 confocal microscope, and the
images were analyzed using the LSM510 image browser software.
Isolation of Mitochondria—Crude heavy and light mitochondrial
fractions were obtained by differential centrifugation as recommended
in OptiPrep Application Sheets (Axis-Shield PoC AS; www.axis-shield-
poc.com/density/dtech.htm). Briefly, MCF-7 cells were collected from
two 150-mm plates and resuspended in 2 ml of buffer A (0.25 M sucrose,
1 mM EDTA, and 10 mM HEPES-NaOH, pH 7.4). Cell suspension was
homogenized with 15–20 passages through a 25-gauge needle. The
homogenate was then centrifuged at 1,000  g for 10 min. The super-
natant was subsequently centrifuged at 3,000  g for 10 min. The pellet
was retained and the supernatant further centrifuged at 17,000  g for
10 min. The last two pellets were termed heavy and light mitochondrial
fractions and used for isopycnic fractionation in an OptiPrep density
gradient.
Fractionation of Organelles with Preformed Density Gradient—Frac-
tionation of the light and heavy mitochondrial pellets was performed in
a continuous 10–30% OptiPrep (iodixanol) gradient according to man-
ufacturer’s recommendations (Axis-Shield PoC AS). Briefly, the gradi-
ent was formed by diffusion of 10/20/25/30% steps for 60 min. Heavy
and light mitochondrial fractions were re-suspended in 5% OptiPrep,
layered on the top of the gradient, and centrifuged in a swinging-bucket
rotor at 80,000  g for 2 h. After unloading the gradient, obtained
fractions were frozen in an ethanol/dry ice bath and stored at 80 °C.
Limited Proteolysis, Alkaline and Urea Extractions—To determine
the sensitivity of CoAsy to protease treatment, a light mitochondrial
fraction (100 g of proteins) was incubated with 1 g of proteinase K for
30 min at room temperature in buffer containing 50 mM Tris-HCl, pH
7.4, 0.25 M sucrose, and 2 mM CaCl2. The reaction was stopped by
adding 2 mM phenylmethylsulfonyl fluoride and boiling in gel loading
buffer. The samples were separated by SDS-PAGE and immunoblotted
for detection of CoAsy, VDAC1, and Mn-SOD.
The same quantity of a light mitochondrial fraction was extracted
with 3 M urea and 0.1 M Na2CO3, pH 11.0, or under neutral conditions
as described previously (30). The pellets and soluble fractions obtained
in all types of extraction were separated by SDS-PAGE and probed with
anti-CoAsy, anti-VDAC1, and anti-Mn-SOD antibodies.
Enzymatic Assays—PPAT and dPCoAK activities were measured as
described previously (27). Enzymatic assays were performed in the
presence or absence of freshly prepared phospholipid vesicles. All phos-
pholipids were dissolved in chloroform and stored at 80 °C in small
aliquots. Appropriate amounts of phospholipid solutions were mixed
and solvent was vaporized in a SpeedVac at room temperature for 1 h.
Lipid vesicles were freshly prepared in 1 assay buffer by vigorous
vortexing of mixed phospholipids followed by sonication for 1 min at
room temperature. The quality of prepared vesicles was analyzed by
phase-contrast microscopy.
RESULTS
The N-terminal Region of CoAsy Possesses a Conserved Hy-
drophobic Stretch—We and others have recently cloned cDNAs
encoding mammalian CoAsy (27–29). Sequence analysis and
biochemical studies revealed that CoAsy is a multidomain pro-
tein, possessing two enzymatic domains: 4PP adenylyltrans-
ferase in the middle and dephospho-CoA kinase at the C ter-
minus. No significant homology to known protein domains or
motifs was reported for the N-terminal region of CoAsy in
previous studies. However, further inspection of CoAsy re-
vealed the presence of a hydrophobic segment, extending from
residues 7 to 29 (Fig. 1). It is followed by a long peptide segment
that is typically hydrophilic. This finding suggested that the
N-terminal sequence of CoAsy might be involved in anchoring
the enzyme to a membranous component of the cell.
CoAsy Is Localized on Mitochondria—To analyze the subcel-
lular localization of CoAsy, we employed immunofluorescent-
confocal microscopy and subcellular fractionation approaches.
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When NIH3T3 cells were transfected with Myc-tagged CoAsy,
the fluorescent signal was localized within discrete structures
in the cytoplasm, resembling mitochondria (Fig. 2A). To con-
firm this, Myc-tagged, CoAsy-transfected cells were treated
with MitoTracker 15 min before fixation. As shown in Fig. 2B,
the green fluorescent signal corresponding to Myc-tagged
CoAsy completely overlaps with the orange fluorescence of
MitoTracker. The specificity of the antibody signal was tested
by probing NIH3T3 cells transfected with empty vector using
both anti-Myc and the fluorescein isothiocyanate-labeled sec-
ondary antibodies. NIH3T3 cells expressing the Myc-tagged
CoAsy constructs were also probed with secondary antibody
alone. In both cases, the fluorescent signal was at background
level (data not shown). Mitochondrial localization of Myc-
CoAsy was also confirmed in transiently transfected human
embryonic kidney 293 cells (data not shown).
A series of CoAsy deletion mutants were constructed to iden-
tify the region involved in targeting the enzyme to mitochon-
dria (Fig. 2A). Initially, we generated and tested two truncated
mutants: Myc-NCoAsy and Myc-dPCoAK. Transient expres-
sion of these constructs in NIH3T3 cells clearly indicated that
these deletions yielded proteins that lose mitochondrial local-
ization (Fig. 2B). Based on these data and the prediction anal-
ysis, we have created a mutant that lacks 29 amino acids from
the N terminus but contains the conserved hydrophobic
stretch. When expressed in NIH3T3 cells, this mutant also
lacked mitochondrial localization (Fig. 2B). Taken together,
these data indicate that CoAsy is localized on mitochondria and
that this association is mediated by the N-terminal sequence.
The Extreme N-terminal Sequences Target CoAsy to Mito-
chondria—Green fluorescent protein has proven to be a pow-
erful and convenient fluorescent tag for monitoring the expres-
sion and subcellular localization of genes of interest, protein
domains, or specific motifs. We therefore cloned the N-terminal
sequence of CoAsy coding the first 29 amino acids into the
pEGFP-N1 mammalian expression vector as described under
“Experimental Procedures.” Immunofluorescent microscopic
analysis showed that cells transfected with control plasmid
pEGFP-N1 exhibited a strong green fluorescent signal
throughout the cells (Fig. 3). In contrast, cells with pEGFP-
CoAsyN construct showed the green fluorescent product
CoAsyN-EGFP to be localized to specific sites in the cytosol,
resembling mitochondria (Fig. 3). To confirm that these sites
correspond to mitochondria, transfected cells were treated with
MitoTracker 15 min before fixation. Converging the two im-
ages, gave a yellow fluorescent pattern, suggesting the colocal-
ization of both fluorescent signals on the same cellular or-
ganelles, namely mitochondria. Based on this finding, we
conclude that the extreme N-terminal sequences of CoAsy,
corresponding to amino acids 1–29, are responsible for mito-
chondrial targeting of CoAsy.
CoAsy Cofractionates with Purified Mitochondria—We have
also employed the technique of subcellular fractionation to
study the localization of CoAsy in MCF-7 cells, which express
significant levels of endogenous enzyme (27). The light and
heavy mitochondrial pellets were obtained from exponentially
growing MCF-7 cells and further fractionated in 10–30%
OptiPrep gradient. Unloaded fractions were resolved by SDS-
PAGE and immunoblotted with antibodies directed against
CoAsy and VDAC1. The results shown in Fig. 4A indicate the
presence of CoAsy in the light mitochondrial fraction and that
its fractionation pattern is similar to that of VDAC1, which is
a specific marker of the mitochondrial outer membrane (34).
FIG. 1. CoAsy possesses a conserved hydrophobic stretch at
the N terminus. The hydrophobicity profile of CoAsy was generated by
TMpred program (Refs. 31–33; www.ch.embnet.org/software/TMPRED_
form.html). A modular domain structure of CoAsy is represented in the
middle. The alignment of the first 30 amino acids of CoA synthases from
various organisms is shown below. The hydrophobic residues are
shaded.
FIG. 2. Mitochondrial localization of CoAsy is mediated by the
N-terminal region. A, modular representation of different CoAsy con-
structs used in this study. The length of deleted mutants is marked
below in amino acids. B, NIH3T3 cells were transiently transfected with
Myc-tagged CoAsy (a–c), dPCoAK (d–f), NCoAsy (g–i), or TMCoAsy
(j–l) plasmids. Cells were incubated with MitoTracker Orange CMTM-
Ros (MTR) before being fixed, permeabilized, and processed for immu-
nofluorescence confocal microscopy using the Myc-tag antibody and
fluorescein isothiocyanate-anti-mouse secondary antibodies. Yellow in
the overlay (merge) images appears where the green fluorescence of
Myc-CoAsy colocalizes with the red fluorescence of MitoTracker Orange
CMTMRos.
Mitochondrial Localization and Activation of CoA Synthase50318









Furthermore, we analyzed CoAsy and catalase (a marker of
peroxisomes) activities in obtained fractions. As shown in Fig.
4B, the dPCoAK activity of CoAsy is present in the same
fractions as VDAC1, whereas catalase activity appears in frac-
tions that correspond to peroxisomes according to the OptiPrep
application manual (Fig. 4C). A similar pattern of distribution
of CoAsy, VDAC1, and catalase was obtained with the use of
the heavy mitochondrial fraction (data not shown). These re-
sults demonstrate that native CoAsy co-fractionates with
mitochondria.
CoAsy Localizes to the Mitochondrial Outer Membrane—To
determine the submitochondrial topology of CoAsy, purified
mitochondria were subjected to limited proteolysis and extrac-
tion under alkaline conditions and with 3 M urea. To ascertain
whether CoAsy is exposed on the mitochondrial surface and is
sensitive to proteolysis, purified mitochondrial fractions were
treated with proteinase K. The reaction products were resolved
by SDS-PAGE and immunoblotted with CoAsy, VDAC1, and
Mn-SOD antibodies. As shown in Fig. 5A, mitochondria-asso-
ciated CoAsy is significantly more sensitive to protease treat-
ment than VDAC1, which forms mitochondrial pores and is
only partially exposed on the surface.
Extraction under neutral conditions indicated that CoAsy,
VDAC1, and Mn-SOD (as a matrix marker) remain associated
with mitochondria (Fig. 5B). The results of an extraction assay
with 3 M urea showed that VDAC1 and Mn-SOD are resistant
to this treatment, whereas a small proportion of CoAsy is
extracted from mitochondria. When the mitochondrial suspen-
sion was treated with 0.1 M Na2CO3, pH 11, the amount of
CoAsy associated with mitochondria was significantly reduced,
but the amount of VDAC1 or Mn-SOD was not altered. These
data suggest that protein-protein interactions may also con-
tribute to the association of CoAsy with the mitochondrial
outer membrane (MOM).
Taken together, these results indicate that CoAsy is a mem-
brane-associated protein that is anchored to the MOM through
its N-terminal region, exposing both enzymatic domains to the
cytosol. In addition, protein-protein interactions seem to be
involved in stabilizing the association of CoAsy with the
membranes.
Growth Factors and Metabolic Regulators Do Not Alter Sub-
cellular Localization of CoAsy—A number of cellular proteins
have been shown to interact with mitochondria in a regulated
manner. Therefore, it was interesting to investigate whether
growth factors and activators of cellular metabolism can mod-
ulate subcellular localization of CoAsy. NIH3T3 cells were
transfected with Myc-CoAsy, starved for 24 h in medium with-
out donor calf serum and stimulated with insulin-like growth
FIG. 4. Subcellular fractionation reveals that endogenous
CoAsy is associated with mitochondrial fractions. A, CoAsy co-
fractionates with VDAC1, a mitochondrial outer membrane protein. A
light mitochondrial fraction isolated from MCF-7 cells by differential
centrifugation was fractionated in 10–30% OptiPrep gradient. Frac-
tions from the gradient were unloaded and numbered from the top. The
dPCoAK activity was measured as described under “Experimental Pro-
cedures” using 5 l from each fraction. Reaction products were sepa-
rated by thin layer chromatography and visualized by autoradiography.
Equal amounts of indicated fractions were resolved by SDS/PAGE and
immunoblotted with antibodies against CoAsy or VDAC1. B, CoAsy is
not present in fractions containing peroxisomes. Distribution of dP-
CoAK () and catalase (E) activities in fractions from the 10–30%
OptiPrepTM gradient. Catalase activity was measured as recom-
mended by OptiPrep manufacturer’s protocol using 25 l from each
fraction in the assay. C, the distribution of organelles from the light
mitochondrial pellet in preformed OptiPrep 10–30% gradient according
to manufacturer’s protocol. The activities of succinate dehydrogenase
(black columns), catalase (white columns), and -galactosidase (gray
columns) correspond to mitochondria, peroxisomes, and lysosomes,
respectively.
FIG. 3. The N-terminal 29 amino ac-
ids of CoAsy localize green fluores-
cent protein exclusively on mito-
chondria. Human embryonic kidney 293
cells were transiently transfected with
pEGFP-N1 vector (a–c) or with pEGFP-
N1-CoAsyN (d–f). Cells were incubated
with MitoTracker Orange CMTMRos
(MTR) before being fixed, permeabilized,
and exposed for immunofluorescence-con-
focal microscopy. The intracellular distri-
bution of green fluorescent protein is
given in green (a, d), mitochondria are
stained in red (b, e), the yellow (c, f) ap-
pears when fluorescence of EGFP and Mi-
toTracker are colocalized.
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factor, EGF, phorbol 12-myristate 13-acetate, or donor calf
serum. Subcellular localization of Myc-CoAsy was analyzed by
confocal-immunofluorescent microscopy using anti-Myc epitope
antibodies. The Myc-CoAsy signal was found exclusively on
mitochondria, and its localization did not alter in cellular re-
sponses to insulin-like growth factor, EGF, donor calf serum, or
phorbol 12-myristate 13-acetate (data not shown).
Modulation of CoAsy Activity by Phospholipids—The activity
of many membrane or membrane-associated proteins is regu-
lated by phospholipids. Studies of the lipid composition of the
MOM in mammalian cells showed that phosphatidylcholine
(PC) and phosphatidylethanolamine (PE) are the main compo-
nents (35). Considering this, we initially investigated the effect
of these two phospholipids on the PPAT and dPCoAK activities
of CoAsy. In this study, we used recombinant CoAsy derived
from a baculoviral expression system. The data presented in
Fig. 6A reveal that both PPAT and dPCoAK activities of CoAsy
are strongly activated by PC- and PE-containing vesicles. We
observed 21- and 9-fold activation of dPCoAK activity by 10 mM
of PE and PC, respectively. The PPAT activity is enhanced 6-
and 2-fold by the same concentration of PE and PC, respectively.
The outcome of this study was reproduced in four independent
experiments. In addition, we tested the effect of phosphatidyl-
serine and phosphatidylinositol, prepared with 10% PC to in-
crease the stability of the vesicles. Addition of these phospho-
lipids into PC-based vesicles had only a small stimulatory
effect on PPAT and dPCoAK activities of CoAsy (data not
shown). It is important to note that the activation of CoAsy by
phospholipids is concentration dependent. Maximum activa-
tion of PPAT activity was observed with 2.5 mM PC/PE,
whereas dPCoAK activity did not reach a plateau even with 20
mM PC/PE (Fig. 6B). This finding demonstrates, for the first
time, that phospholipids, such as PC and PE, are potent mod-
ulators of CoAsy activity in vitro.
DISCUSSION
The CoA biosynthetic pathway was deciphered more than 20
years ago. The enzymes mediating the five universal steps in
CoA biosynthesis have been purified from many sources and
extensively characterized. However, molecular cloning of cor-
responding cDNAs has been accomplished only recently. The
availability of molecular reagents that have evolved from these
studies provided the necessary tools for the elucidation of reg-
ulatory mechanisms governing CoA biosynthesis. The focus of
this study was on the analysis of subcellular localization and
regulation of CoAsy, the enzyme that mediates the last two
stages of CoA biosynthesis.
The compartmentalization of the CoA biosynthetic machin-
ery has been the subject of many studies. It has been demon-
strated that the first three enzymes of the CoA biosynthetic
pathway are cytosolic proteins. To date, subcellular localization
of CoAsy has not been clearly defined. Both PPAT and dPCoAK
activities of CoAsy were reported to be present in the cytosol,
mitochondrial outer membrane and mitochondrial matrix (3,
25, 26). The data presented in this study clearly demonstrate
that CoAsy is localized on mitochondria. A panel of deletion
mutants was used to demonstrate that the conserved hydro-
phobic stretch at the N terminus anchors CoAsy to mitochon-
dria. Based on protease sensitivity assay and extraction of
CoAsy from purified mitochondria, we propose that the N-
terminal conserved hydrophobic stretch, and perhaps protein-
protein interactions, anchor the enzyme on the mitochondrial
outer membrane. Moreover, we provide evidence that CoAsy is
not localized on peroxisomes, which are, together with mito-
chondria, the main stores of cellular CoA.
The biosynthesis of CoA on the MOM may facilitate its
transport into mitochondria or the generation of CoA-thio-
esters. The existence of a specific CoA transporter on the mi-
tochondrial inner membrane has been reported (36). It was
shown that the transport of CoA into mitochondria is driven by
the membrane potential, which is stimulated by substrates of
the tricarboxylic acid cycle, such as succinate, malate, and
-ketoglutarate. It is important to note that the pores on the
mitochondrial outer membrane are big enough for CoA to
translocate freely into the inter membrane space.
Several CoA- or CoA thioester-modifying enzymes are asso-
ciated with the MOM. For example, long chain acyl-CoA syn-
thase uses CoA and long chain fatty acids to generate acyl-CoA
(37). Production of acyl-CoA is the first step in a series of events
leading to the degradation of fatty acids by -oxidation. Long
chain acyl-CoA synthase was found in complex with VDAC (38,
39), and it is possible that anchoring of CoA synthase to the
FIG. 5. CoAsy is localized on the outer mitochondrial mem-
brane. A, mitochondria-associated CoAsy is sensitive to protease treat-
ment. The light mitochondrial fraction (100 g of proteins) was treated
with or without proteinase K for 30 min at room temperature. The
samples were resolved by SDS-PAGE and analyzed by immunoblotting.
B, sensitivity of CoAsy to extraction with 3 M urea or under alkaline
conditions. The light mitochondrial fraction (100 g of proteins) was
extracted under neutral (isotonic buffer) or alkaline (0.1 M Na2CO3, pH
11) conditions or in the presence of 3 M urea. The insoluble pellet (P) and
the supernatant (S) of these extractions were resolved by SDS-PAGE
and analyzed by immunoblotting with CoAsy, VDAC1 (mitochondrial
outer membrane marker), and Mn-SOD (mitochondrial matrix marker)
antibodies.
FIG. 6. Activation of CoAsy by phospholipids. A, PC and PE
activate both PPAT and dPCoAK activities of CoAsy. Affinity-purified
preparations of CoAsy obtained from a baculovirus expression system
were used in this study. The assays were performed as described under
“Experimental Procedures” using 0.1 g of recombinant protein in the
presence or absence of 10 mM phospholipids. Reaction products were
resolved by paper chromatography. The position of radiolabeled prod-
ucts and enzymatic activity alteration were determined using a filmless
autoradiographic analysis system (Bio-Rad). PPAT and dPCoAK activ-
ities of CoAsy are given as black and white columns respectively. y-axis
value represents a ratio between phospholipid treated and non-treated
enzyme activities. B, concentration-dependent stimulation of PPAT and
dPCoAK activities of CoAsy by phospholipids. The assay was performed
in the same way as described in above, except that vesicles were
prepared from a 1:1 mixture of PC and PE. , PPAT activities of CoAsy;
E, dPCoAK activities of CoAsy. y-axis value represents a ratio between
phospholipid treated and non-treated enzyme activities. x-axis repre-
sents the concentration of phospholipids in the reaction mixture.
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outer mitochondrial membrane could be facilitated by specific
interactions with VDAC or VDAC-associated proteins. Another
example of a MOM-associated protein is acetyl-CoA carboxyl-
ase 2, which catalyzes the formation of malonyl-CoA from
acetyl-CoA (40). Similar to CoA synthase, acetyl-CoA carboxyl-
ase 2 is targeted into the MOM in the NH2 in–COOHout orien-
tation via a unique N-terminal hydrophobic region.
So far, sequence determinants necessary for targeting of
cellular proteins to the MOM have not been clearly defined. It
has been proposed that proteins with a moderately hydrophobic
stretch and adjacent positively charged amino acids favor tar-
geting to the MOM (24, 41). In contrast, proteins with highly
hydrophobic stretch and without net positive charges within
the flanking region are targeted to the ER, the Golgi, and the
plasma membranes. We are currently testing by site-directed
mutagenesis and confocal microscopy whether these criteria
apply for CoAsy.
The regulation of CoA synthase activity is not well under-
stood. No physiological regulators of CoAsy have been identi-
fied so far. We demonstrate in this study that PE and PC, the
main components of the MOM, are potent activators of CoAsy
in vitro. We propose that binding of 4PP to the PPAT domain
induces a conformational change, which primes CoAsy for ac-
tivation by membrane phospholipids. The interaction between
CoAsy and phospholipids may remove a conformational con-
straint on both the PPAT and dPCoAK activities. The region of
CoAsy involved in lipid activation remains to be identified. Our
preliminary data indicate that sequences within the dPCoAK
domain mediate phospholipid-induced activation of CoA syn-
thase.2 Overall, these findings indicate that the last two stages
of CoA biosynthesis take place on the mitochondrial outer
membrane and that the activity of CoA synthase is regulated
by phospholipids.
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